TNF and pancreatic neoplasm: These results suggest that pancreatic tumor lines lacking Mgat5 are more sensitive to the death-inducing activity of ligands belonging to the TNF superfamily, with some Mgat5-KO lines exhibiting enhanced sensitivity to TNF-α and others exhibiting enhanced sensitivity to TRAIL.